Mon, 20 Oct, 2014

INVESTMENT NEWS

Market Reports-
Company Search

Search QCK.COM


Mon, 20 Oct, 2014
The London market tumbled back into negative territory on Monday after downbeat US earnings rekindled worries about the health of the global economy.
Mon, 20 Oct, 2014
Travel stocks were putting in a decent performance on Monday, following recent volatile trading amid the growing Ebola crisis.
Mon, 20 Oct, 2014
An upgrade from Liberum Capital helped lift shares in Lonmin on Monday. The broker now recommends investors keep 'hold' of the mining stock.
Mon, 20 Oct, 2014
Anyone hoping for a positive start to the week on the stock market following the recent volatility would have been disappointed on Monday as UK equities suffered more steep falls.
Mon, 20 Oct, 2014
UK stocks declined on Monday morning on a quiet day for economic data, with investors still showing caution following a volatile week for markets last week.
Mon, 20 Oct, 2014
UK stocks are expected to get Monday's session off to a positive start following a rally in the US on Friday, but analysts have warned last week's volatility may well run into this one.
Fri, 17 Oct, 2014
The FTSE ended Friday's session on a positive note after a week of volatile and largely negative trading.
Fri, 17 Oct, 2014
Tullow Oil, Shell and a number of other oil companies were all trading in positive territory on Friday afternoon thanks to a continued rebound in crude prices.
Fri, 17 Oct, 2014
A continued rebound in crude prices on Friday saw firms in the oil services sector rise after the price of the commodity collapsed over the past few weeks. Ophir and Enquest were both strong risers.
Fri, 17 Oct, 2014
UK stocks staged a partial recovery on Friday following a turnaround in sentiment on Wall Street, with oil producers leading the upside after a bounce in oil prices from their recent lows.
Fri, 17 Oct, 2014
UK stock markets recovered slightly on Friday morning as investors looked for bargains in the aftermath of recent volatility, which sent equities to a 16-month low the previous session
Fri, 17 Oct, 2014
Thanks to a weak performance from Japan and a mixed picture in the US overnight, London-listed stocks are expected to move lower once again at Friday's opening bell.
Thu, 16 Oct, 2014
Thursday's session closed with modest losses as equities tried to recover from the previous day's spike in volatility, amid continuing concerns surrounding the financial stability of Greece and more bad news for blue chip pharmaceutical Shire.
Thu, 16 Oct, 2014
Shire, which dropped 22% on Wednesday after Abbvie said it was reconsidering its bid for the firm, was down by a further 8% after the US group advised shareholders vote against the takeover due to changes in the US tax law. Abbvie said that these changes had introduced "an unacceptable level of uncertainty" into the deal. Engineering group GKN got a lift from an upgrade out of Exane BNP Paribas to 'outperform' from 'neutral'.
Thu, 16 Oct, 2014
Gaming giant Bwin.party rose after it reported a 2% rise in third quarter revenue to 148.7m as an increase in sports betting sales offset a fall in bingo, casino and poker. Sports betting revenue advanced 11% to 58.8m, driven by higher margins, the World Cup and growth in the number of people using their mobile phones to gamble
Thu, 16 Oct, 2014
In spite of an initial 'dead cat bounce' in early deals, London's FTSE 100 tanked again on Thursday morning with the index sinking to levels not seen since June 2013
Thu, 16 Oct, 2014
UK stocks attempted to claw their way back on Thursday, though early gains were quickly trimmed as shaky investors continued to tread nervously after a 'flash-crash' in US Treasury yields in the previous session.
Thu, 16 Oct, 2014
London-listed stocks are expected to make a modest recovery following sharp losses in Tuesday's session.
Wed, 15 Oct, 2014
The FTSE tumbled 2.83% on Wednesday thanks to weak data, news of Abbvie's reconsideration of its bid for Shire and a slide in US stocks, particularly on the Dow Jones.
Wed, 15 Oct, 2014
The share price of UK pharmaceutical group Shire collapsed on Wednesday after US drugmaker Abbvie said it was reconsidering its offer in light of the US Treasury's new rules regarding the takeover of foreign companies, specifically tax inversion deals. Shire pointed out it would be due a break-up fee of roughly $1.64bn if the deal falls through, but that didn't stop the latter's shares from sinking by nearly 23%.
rss